English Journal

Shanbhag VK.
General dentistry.Gen Dent.2016 Jan-Feb;64(1):e10-1.
This article reviews the hemostatic properties of snake venoms and their potential clinical application.
PMID 26742177

Hemocoagulase agkistrodon-induced anaphylactic shock: A case report and literature review.

Xu YY, Ma XH, Zhang SJ.
International journal of clinical pharmacology and therapeutics.Int J Clin Pharmacol Ther.2015 Dec 4. [Epub ahead of print]
Hemocoagulase agkistrodon for injection is the national first-class new drug of China with good hemostatic function and safety for capillary hemorrhage in abdominal incision of surgical patients. Adverse drug reactions (ADRs) to hemocoagulase agkistrodon are rarely reported. In this paper, we descri
PMID 26636421

Prognostic predictors of sudden sensorineural hearing loss in defibrinogenation therapy.

Oya R1, Horii A2, Akazawa H3, Osaki Y4, Inohara H1.
Acta oto-laryngologica.Acta Otolaryngol.2015 Nov 17:1-6. [Epub ahead of print]
CONCLUSIONS: Defibrinogenation therapy rather than corticosteroids therapy should be chosen for patients specifically with profound hearing loss and with initial high fibrinogen.OBJECTIVES: Corticosteroids therapy is the standard treatment for sudden sensorineural hearing loss (SSNHL) and prognostic
PMID 26573379